160 related articles for article (PubMed ID: 8024242)
41. Familial male pseudohermaphroditism without gynecomastia due to deficient testicular 17-ketosteroid reductase activity.
Givens JR; Wiser WL; Summitt RL; Kerber IJ; Andersen RN; Pittaway DE; Fish SA
N Engl J Med; 1974 Oct; 291(18):938-44. PubMed ID: 4278097
[No Abstract] [Full Text] [Related]
42. Pituitary-gonadal function in Klinefelter syndrome before and during puberty.
Salbenblatt JA; Bender BG; Puck MH; Robinson A; Faiman C; Winter JS
Pediatr Res; 1985 Jan; 19(1):82-6. PubMed ID: 3918293
[TBL] [Abstract][Full Text] [Related]
43. [Changes in leucocytic estrogen receptor levels in patients with gynecomastia].
Zhou DJ; Zhang JQ; Qiao DB
Zhonghua Nei Ke Za Zhi; 1991 Mar; 30(3):160-2, 189. PubMed ID: 1874085
[TBL] [Abstract][Full Text] [Related]
44. Gynecomastia in men following antineoplastic therapy.
Trump DL; Pavy MD; Staal S
Arch Intern Med; 1982 Mar; 142(3):511-3. PubMed ID: 6802094
[TBL] [Abstract][Full Text] [Related]
45. Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.
Biglia A; Blanco JL; Martínez E; Domingo P; Casamitjana R; Sambeat M; Milinkovic A; Garcia M; Laguno M; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
Clin Infect Dis; 2004 Nov; 39(10):1514-9. PubMed ID: 15546089
[TBL] [Abstract][Full Text] [Related]
46. Male pseudohermaphroditism due to 5 alpha reductase deficiency associated with gynecomastia.
Mendonça BB; Batista MC; Arnhold IJ; Nicolau W; Madureira G; Lando VS; Kohek MB; Carvalho DG; Bloise W
Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):66-8. PubMed ID: 3441728
[No Abstract] [Full Text] [Related]
47. Hormonal profile of Leydig cell tumors with gynecomastia.
Bercovici JP; Nahoul K
Prog Clin Biol Res; 1985; 203():503-6. PubMed ID: 3832101
[No Abstract] [Full Text] [Related]
48. Hormonal modulation of invitro biosynthesis of inhibin like peptide by human prostate.
Vanage GR; Phadke MA; Bandivdekar AH; Sheth AR
Andrologia; 1990; 22(1):7-11. PubMed ID: 2126421
[TBL] [Abstract][Full Text] [Related]
49. Effect of synthetic LH-RH and hCG administration on plasma testosterone, androstenedione, and estradiol 17beta levels in normal men and in patients with idiopathic oligospermia.
Masala A; Delitala G; Alagna S; DeVilla L; Rovasio PP; Borroni G
Int J Fertil; 1979; 24(1):71-3. PubMed ID: 37185
[TBL] [Abstract][Full Text] [Related]
50. Impaired prolactin stimulation by estrogens in man.
Sultan C; Descomps B; Crastes de Paulet A; Jean R
Horm Res; 1979; 11(6):337-8. PubMed ID: 119697
[No Abstract] [Full Text] [Related]
51. [The significance of gynecomastia in general practice].
von Werder K
Fortschr Med; 1989 Apr; 107(12):271-3. PubMed ID: 2659478
[TBL] [Abstract][Full Text] [Related]
52. Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia.
Pont A; Goldman ES; Sugar AM; Siiteri PK; Stevens DA
Arch Intern Med; 1985 Aug; 145(8):1429-31. PubMed ID: 4040740
[TBL] [Abstract][Full Text] [Related]
53. [An uncommon cause of gynecomastia: testicular Leydig cell tumor. Hormonal profile before and after orchiectomy].
Bertola G; Giambona S; Balza G; Sironi C; Colombo E; Santangelo M; Di Nuovo F
Recenti Prog Med; 2006 Feb; 97(2):85-8. PubMed ID: 16671273
[TBL] [Abstract][Full Text] [Related]
54. Stimulation of adenosine 3',5'-monophosphate and sex steroids in the spermatic venous blood after human chorionic gonadotropin injection into human testes.
Yasukawa A; Usui T; Nihira H; Miyachi Y
J Clin Endocrinol Metab; 1981 Apr; 52(4):688-91. PubMed ID: 6259190
[TBL] [Abstract][Full Text] [Related]
55. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
[TBL] [Abstract][Full Text] [Related]
56. Reversal of idiopathic hypogonadotropic hypogonadism.
Raivio T; Falardeau J; Dwyer A; Quinton R; Hayes FJ; Hughes VA; Cole LW; Pearce SH; Lee H; Boepple P; Crowley WF; Pitteloud N
N Engl J Med; 2007 Aug; 357(9):863-73. PubMed ID: 17761590
[TBL] [Abstract][Full Text] [Related]
57. [Persistent puberal gynecomastia. Diagnosis and treatment].
Franchella A; Pelizzo G; Nanetti C; De Santis V; Bagni B
Minerva Chir; 1988 Mar; 43(5):401-5. PubMed ID: 3135515
[No Abstract] [Full Text] [Related]
58. [Endocrinological aspects of puberal gynecomastia].
Cicognani A; Villa MP; Cassio A; Ventura D; Becca A; Tassinari D; Cacciari E
Minerva Pediatr; 1981 Jun; 33(11):507-14. PubMed ID: 6789052
[No Abstract] [Full Text] [Related]
59. [Gynecomastia and high serum testosterone in a 10 year old boy].
Viinikka L; Hammond GL; Hortling H; Leinonen P; Vihko R
Duodecim; 1981; 97(17):1417-9. PubMed ID: 7327132
[No Abstract] [Full Text] [Related]
60. [Treatment of marked gynecomastia in puberty with tamoxifen].
König R; Schönberger W; Neumann P; Benes P; Grimm W
Klin Padiatr; 1987; 199(6):389-91. PubMed ID: 3123765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
